SCHEMBL1633423

SCHEMBL1633423

CN(C)CCOc1ccc2cnc(Nc3ccc(S(N)(=O)=O)cc3)nc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 4/20 0.63
CDK4 P11802 3/20 0.54
CCND1 P24385 3/20 0.54
CCND2 P30279 2/20 0.54
CCND3 P30281 2/20 0.54
FGFR1 P11362 1/20 0.45
CA2 P00918 8/20 0.45
CA1 P00915 6/20 0.45
CA9 Q16790 6/20 0.45
CA12 O43570 2/20 0.44
CDK2 P24941 4/20 0.43
CCNA2 P20248 1/20 0.43
CCNA1 P78396 1/20 0.43
IGF1R P08069 1/20 0.43
CDK1 P06493 3/20 0.43
CDK9 P50750 3/20 0.43
CCNT1 O60563 2/20 0.43
CDK7 P50613 2/20 0.43
CCNH P51946 2/20 0.43
CCNB1 P14635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633099 0.84 IKBKB (0.65) IKBKBCDK4CCND1CCND2CCND3
SCHEMBL27780313 0.80 IKBKB (0.50) IKBKBCDK4CCND1FGFR1CA2
SCHEMBL1633533 0.79 IKBKB (0.44) IKBKBCDK4CCND1CCND3CA2
SCHEMBL1634724 0.79 IKBKB (0.62) IKBKBCA2CA1CA9CA12
SCHEMBL1571219 0.78 IKBKB (0.48) IKBKBCA2CA1CA9CA12
SCHEMBL29576177 0.78 CDK4 (0.58) IKBKBCDK4CCND1CCND2CCND3
SCHEMBL1633690 0.78 IKBKB (0.57) IKBKBCA2CA1CA9CA12
SCHEMBL1633527 0.77 IKBKB (0.51) IKBKBCDK4CCND1CA2CA1
SCHEMBL1633261 0.77 IKBKB (0.55) IKBKBCA2CA1CA9CA12
SCHEMBL1633891 0.76 IKBKB (0.54) IKBKBCDK4CCND1CCND3CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed